2019
DOI: 10.1186/s13046-019-1086-2
|View full text |Cite
|
Sign up to set email alerts
|

3D models in the new era of immune oncology: focus on T cells, CAF and ECM

Abstract: Immune checkpoint inhibitor therapy has changed clinical practice for patients with different cancers, since these agents have demonstrated a significant improvement of overall survival and are effective in many patients. However, an intrinsic or acquired resistance frequently occur and biomarkers predictive of responsiveness should help in patient selection and in defining the adequate treatment options. A deep analysis of the complexity of the tumor microenvironment is likely to further advance the field and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
70
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 85 publications
(70 citation statements)
references
References 157 publications
(167 reference statements)
0
70
0
Order By: Relevance
“…Immune cells are the major cellular component of the tumor microenvironment and strongly impact prognosis and response to the therapies. 65 However, the impact of hematopoietic and immune cells, as the critical components of the tumor niche, on the tumor in 3D model is poorly understood. Ando et al fabricated a 3D tumor model that recapitulates the hypoxic microenvironment of cancer.…”
Section: Recapitulation Of Tumor Microenvironmentmentioning
confidence: 99%
“…Immune cells are the major cellular component of the tumor microenvironment and strongly impact prognosis and response to the therapies. 65 However, the impact of hematopoietic and immune cells, as the critical components of the tumor niche, on the tumor in 3D model is poorly understood. Ando et al fabricated a 3D tumor model that recapitulates the hypoxic microenvironment of cancer.…”
Section: Recapitulation Of Tumor Microenvironmentmentioning
confidence: 99%
“…The plethora of rodent xenograft models available for preclinical investigation often lack a fully functioning immune system or a completely relevant human tumor microenvironment (TME), and thus fail to accurately capture the complexities and behaviors of human solid tumors (5). New approaches to the evaluation of patient-derived tumor explants, slices, organoids, and spheroids may partially address this issue (6,7). However, all of these require some degree of laboratory manipulation and all lack access to physiological influences only present in the cancer patient including, but not limited to, human circulation and metabolism.…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, cells inhabiting a rigid surface without a 3D elastic fibrous meshwork (i.e., the extracellular matrix [ECM]) cannot normally response the physical or biochemical cues from the surrounding physiological matrix substrate [1][2][3][4][5]. Recently, in efforts to target the tumor microenvironment for improving both the effectiveness and efficiency of cancer therapeutics, several studies such as immunotherapy, tumor vasculature, or ECM remodeling has been led to a new era and yielded novel insights [6][7][8]. For example, extravasated T lymphocytes infiltrated into the stromal ECM for migrating to the targeted tumor sites has been demonstrated in 3D cell culture models [9][10][11].…”
Section: Introductionmentioning
confidence: 99%